The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Midkine Binds to Anaplastic Lymphoma Kinase (ALK) and Acts as a Growth Factor for Different Cell Types
Open accessAbstract
Midkine (MK) is a developmentally regulated, secreted growth factor homologous to pleiotrophin (PTN). To investigate the potential role of MK in tumor growth, we expressed MK in human SW-13 cells and studied receptor binding, signal transduction, and activity of MK. The MK protein stimulates soft agar colony formation in vitro and tumor growth of SW-13 cells in athymic nude mice, as well as proliferation of human endothelial cells from brain microvasculature and umbilical vein (HUVEC) in the low ng/ml range. MK binds to anaplastic lymphoma kinase (ALK), the receptor for PTN, with an apparent K(d) of 170 pm in intact cells, and this receptor binding of MK is competed by PTN with an apparent K(d) of approximately 20 pm. Monoclonal antibodies raised against the extracellular ligand-binding domain of ALK inhibit ALK receptor binding of MK as well as MK-stimulated colony formation of SW-13 cells. Furthermore, MK stimulates ALK phosphorylation in WI-38 human fibroblasts and activates PI3-kinase and MAP kinase signal transduction in WI-38, HUVEC, neuroblastoma (SH SY-5Y) and glioblastoma (U87MG) cells that express the ALK protein. We conclude that MK can act as a growth, survival, and angiogenic factor during tumorigenesis and signals through the ALK receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Derivation of specific antibody‐producing tissue culture and tumor lines by cell fusion
Köhler, G., & Milstein, C. (1976) · European Journal of Immunology · doi:10.1002/eji.1830060713 · Cited by 1,922
Iwahara, T., Fujimoto, J., Wen, D., Cupples, R., Bucay, N., Arakawa, T., Mori, S., Ratzkin, B., & Yamamoto, T. (1997) · Oncogene · doi:10.1038/sj.onc.1200849 · Cited by 726
Growth factors in development, transformation, and tumorigenesis
Cross, M., & Dexter, T. M. (1991) · Cell · doi:10.1016/0092-8674(91)90638-f · Cited by 694
Identification of Anaplastic Lymphoma Kinase as a Receptor for the Growth Factor Pleiotrophin
Stoica, G. E., Kuo, A., Aigner, A., Sunitha, I., Souttou, B., Malerczyk, C., Caughey, D. J., Wen, D., Karavanov, A., Riegel, A. T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010660200 · Cited by 382
Self-citationMaeda, N., Ichihara-Tanaka, K., Kimura, T., Kadomatsu, K., Muramatsu, T., & Noda, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12474 · Cited by 315
Mitsiadis, T. A., Salmivirta, M., Muramatsu, T., Muramatsu, H., Rauvala, H., Lehtonen, E., Jalkanen, M., & Thesleff, I. (1995) · Development · doi:10.1242/dev.121.1.37 · Cited by 292
Maeda, N., Nishiwaki, T., Shintani, T., Hamanaka, H., & Noda, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21446 · Cited by 282
An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis.
Choudhuri, R., Zhang, H. T., Donnini, S., Ziche, M., & Bicknell, R. (1997) · PubMed · Cited by 279
Kadomatsu, K., Huang, R. P., Suganuma, T., Murata, F., & Muramatsu, T. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.3.607 · Cited by 256
Tsutsui, J., Kadomatsu, K., Matsubara, S., Nakagawara, A., Hamanoue, M., Takao, S., Shimazu, H., Ohi, Y., & Muramatsu, T. (1993) · PubMed · Cited by 236
Maeda, N., & Noda, M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.1.203 · Cited by 224
Fang, W., Hartmann, N., Chow, D. T., Riegel, A. T., & Wellstein, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35692-8 · Cited by 219
Self-citationDifferential expression of pleiotrophin and midkine in advanced neuroblastomas.
Nakagawara, A., Milbrandt, J., Muramatsu, T., Deuel, T. F., Zhao, H., Cnaan, A., & Brodeur, G. M. (1995) · PubMed · Cited by 204
Neointima formation in a restenosis model is suppressed in midkine-deficient mice
Horiba, M., Kadomatsu, K., Nakamura, E., Muramatsu, H., Ikematsu, S., Sakuma, S., Hayashi, K., Yuzawa, Y., Matsuo, S., Kuzuya, M., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7208 · Cited by 193
Burgess, W. H., Dionne, C. A., Kaplow, J., Mudd, R., Friesel, R., Zilberstein, A., Schlessinger, J., & Jaye, M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.9.4770 · Cited by 192
(1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.02084.x · Cited by 189
Pleiotrophin Signaling through Anaplastic Lymphoma Kinase Is Rate-limiting for Glioblastoma Growth
Powers, C., Aigner, A., Stoica, G. E., McDonnell, K., & Wellstein, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112354200 · Cited by 183
Self-citationTomomura, M., Kadomatsu, K., Matsubara, S., & Muramatsu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)87013-2 · Cited by 175
O’Brien, T., Cranston, D., Fuggle, S., Bicknell, R., & Harris, A. L. (1996) · PubMed · Cited by 168
LDL Receptor-Related Protein as a Component of the Midkine Receptor
Muramatsu, H., Zou, K., Sakaguchi, N., Ikematsu, S., Sakuma, S., & Muramatsu, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2549 · Cited by 167
Czubayko, F., Schulte, A. M., Berchem, G. J., & Wellstein, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14753 · Cited by 162
Self-citationHaptotactic Migration Induced by Midkine
Qi, M., Ikematsu, S., Maeda, N., Ichihara-Tanaka, K., Sakuma, S., Noda, M., Muramatsu, T., & Kadomatsu, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005911200 · Cited by 151
Midkine induces the transformation of NIH3T3 cells
Kadomatsu, K., Hagihara, M., Akhter, S., Fan, Q.-W., Muramatsu, H., & Muramatsu, T. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.58 · Cited by 148
Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice.
Chauhan, A. K., Li, Y. S., & Deuel, T. F. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.679 · Cited by 138
Wellstein, A., Fang, W. J., Khatri, A., Lu, Y., Swain, S. M., Dickson, R. B., Sasse, J., Riegel, A. T., & Lippman, M. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45920-0 · Cited by 130
Self-citationTumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors.
Czubayko, F., Smith, R. V., Chung, H. C., & Wellstein, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46920-7 · Cited by 123
Self-citationMitogenic properties of a new endothelial cell growth factor related to pleiotrophin
Courty, J., Dauchel, M. C., Caruelle, D., Perderiset, M., & Barritault, D. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81267-7 · Cited by 123
Muramatsu, T. (1993) · The International Journal of Developmental Biology · doi:10.1387/ijdb.8507561 · Cited by 118
Increased expression of midkine during the progression of human astrocytomas
Mishima, K., Asai, A., Kadomatsu, K., Ino, Y., Nomura, K., Narita, Y., Muramatsu, T., & Kirino, T. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00619-8 · Cited by 110
Wellstein, A., Zugmaier, G., Califano, J. A., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.10.716 · Cited by 105
Self-citationNo Obvious Abnormality in Mice Deficient in Receptor Protein Tyrosine Phosphatase β
Harroch, S., Palmeri, M., Rosenbluth, J., Custer, A. W., Okigaki, M., Shrager, P. G., Blum, M., Buxbaum, J. D., & Schlessinger, J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7706-7715.2000 · Cited by 104
Matsubara, S., Tomomura, M., Kadomatsu, K., & Muramatsu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38868-4 · Cited by 99
Midkine, a Novel Neurotrophic Factor, Is Present in Senile Plaques of Alzheimer Disease
Yasuhara, O., Muramatsu, H., Kim, S. U., Muramatsu, T., Maruta, H., & McGeer, P. L. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1406 · Cited by 99
Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth.
Czubayko, F., Riegel, A. T., & Wellstein, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31970-1 · Cited by 94
Self-citationMitogenic and In Vitro Angiogenic Activity of Human Recombinant Heparin Affin Regulatory Peptide
Laaroubi, K., Delbé, J., Vacherot, F., Desgranges, P., Tardieu, M., Jaye, M., Barritault, D., & Courty, J. (1994) · Growth Factors · doi:10.3109/08977199409010982 · Cited by 91
A retinoic acid responsive gene, MK, produces a secreted protein with heparin binding activity
Tomomura, M., Kadomatsu, K., Nakamoto, M., Muramatsu, H., Kondoh, H., Imagawa, K., & Muramatsu, T. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91189-y · Cited by 88
Kretschmer, P. J., Fairhurst, J. L., Decker, M. M., Chan, C. P., Gluzman, Y., Böhlen, P., & Kovesdi, I. (1991) · Growth Factors · doi:10.3109/08977199109000275 · Cited by 76
Souttou, B., Juhl, H. H., Clark, J. H., Röckseisen, M., Klomp, H.-J., Raulais, D., Vigny, M., & Wellstein, A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.19.1468 · Cited by 75
Self-citationSignal Transduction Pathways Involved in the Mitogenic Activity of Pleiotrophin
Souttou, B., Ahmad, S., Riegel, A. T., & Wellstein, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19588 · Cited by 70
Self-citationBöhlen, P., & Kovesdi, I. (1991) · Progress in Growth Factor Research · doi:10.1016/s0955-2235(05)80005-5 · Cited by 69
Pleiotrophin can be rate-limiting for pancreatic cancer cell growth.
Weber, D., Klomp, H.-J., Czubayko, F., Wellstein, A., & Juhl, H. H. (2000) · PubMed · Cited by 65
Self-citationMK: a pluripotential embryonic stem-cell-derived neuroregulatory factor
Nurcombe, V., Fraser, N., Herlaar, E., & Heath, J. K. (1992) · Development · doi:10.1242/dev.116.4.1175 · Cited by 63
Ratovitski, E. A., Kotzbauer, P. T., Milbrandt, J., Lowenstein, C. J., & Burrow, C. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3654 · Cited by 62
A new heparin binding protein regulated by retinoic acid from chick embryo
Raulais, D., Chevallier, O., Guettet, C., Duprez, D., Courtois, Y., & Vigny, M. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91475-r · Cited by 56
Wellstein, A., Lupu, R., Zugmaier, G., Flamm, S., Cheville, A. L., Bovi, P. D., Basilico, C., Lippman, M. E., & Kern, F. (1990) · PubMed · Cited by 55
Self-citationJäger, R., List, B., Knabbe, C., Souttou, B., Raulais, D., Zeiler, T. A., Wellstein, A., Aigner, A. M., Neubauer, A., & Zugmaier, G. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600202 · Cited by 53
Self-citationSchulte, A. M., Malerczyk, C., Cabal-Manzano, R. H., Gajarsa, J. J., List, H.-J., Riegel, A. T., & Wellstein, A. (2000) · Oncogene · doi:10.1038/sj.onc.1203742 · Cited by 49
Self-citationSignificance of the expression of the growth factor pleiotrophin in pancreatic cancer patients.
Klomp, H.-J., Zernial, O., Flachmann, S., et al. (2002) · PubMed · Cited by 48
Biochemical and mitogenic properties of the heparin-binding growth factor HARP
Laaroubi, K., Vacherot, F., Delbé, J., Caruelle, D., Barritault, D., & Courty, J. (1995) · Progress in Growth Factor Research · doi:10.1016/0955-2235(95)00002-x · Cited by 19
Qiu, L., Escalante, C. R., Aggarwal, A. K., Wilson, P. D., & Burrow, C. R. (2000) · Biochemistry · doi:10.1021/bi991519e · Cited by 15
Takada, T., Kinkori, T., Muramatsu, H., Hayakawa, A., Torii, S., & Muramatsu, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7873 · Cited by 15
Cited by
The anaplastic lymphoma kinase in the pathogenesis of cancer
Chiarle, R., Voena, C., Ambrogio, C., Piva, R., & Inghirami, G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2291 · Cited by 882
Zou, H. Y., Li, Q., Lee, J. H., Arango, M. E., McDonnell, S. R., Yamazaki, S., Koudriakova, T. B., Alton, G., Cui, J. J., Kung, P.-P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4443 · Cited by 745
Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate
Sugahara, K., Mikami, T., Uyama, T., Mizuguchi, S., Nomura, K., & Kitagawa, H. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.09.011 · Cited by 694
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Hallberg, B., & Palmer, R. H. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3580 · Cited by 645
Anaplastic lymphoma kinase: signalling in development and disease
Palmer, R. H., Vernersson, E., Grabbe, C., & Hallberg, B. (2009) · Biochemical Journal · doi:10.1042/bj20090387 · Cited by 423
Metadata
- Authors
- Stoica, G. E., Kuo, A., Powers, C., Bowden, E. T., Sale, E. B., Riegel, A. T., & Wellstein, A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-09
- Volume
- 277
- Issue
- 39
- Pages
- 35990-35998
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2009742890
- Cited by
- 357
- References
- 51
- FWCI
- 8.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.